lucia5354
Lv57
1510 积分
2023-12-18 加入
-
Myelodysplastic Syndromes
10天前
已完结
-
Camu-camu decreases hepatic steatosis and liver injury markers in overweight, hypertriglyceridemic individuals: A randomized crossover trial
22天前
已完结
-
Anti-vascular endothelial growth factor biosimilars for neovascular age-related macular degeneration
27天前
已完结
-
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation
2个月前
已完结
-
Health-related quality of life in early-stage Hodgkin lymphoma: a longitudinal analysis of the ABVD arm in the randomized controlled trial HD.6
3个月前
已完结
-
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
3个月前
已完结
-
Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial
3个月前
已完结
-
Efficacy and Safety of Butylphthalide in Patients With Acute Ischemic Stroke
3个月前
已完结
-
A randomized controlled trial of betamethasone on fatigue in patients with advanced cancer
4个月前
已完结
-
Sintilimab plus a bevacizumab biosimilar (IBI305) versus sorafenib in unresectable hepatocellular carcinoma (ORIENT-32): a randomised, open-label, phase 2–3 study
4个月前
已完结